Skip to content

The Effect and Applicability of CBT-Based Weight Loss Treatment Model in Obese Patients With Comorbid Depression in Health Care

CBT-Based Weight Loss Treatment Model in Obese Patients With Comorbid Depression. Effect on Eating Behavior, Weight Loss, Mood, and Risk of Coronary Artery Disease and Diabetes.

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04513587
Acronym
PsyCognObe2
Enrollment
80
Registered
2020-08-14
Start date
2019-09-01
Completion date
2024-12-31
Last updated
2024-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive Behavioral Therapy, Depression, Obesity, Weight Loss

Brief summary

The aim of this study is find out how CBT-based weight loss program affects on eating behavior, weight loss, mood symptoms and risk for coronary heart diseases and type 2 diabetes and applicability of the program to obesity treatment among patients with comorbid depression. Our hypothesis is that the CBT-based intervention improves long-term weight management results and supports positively the change in eating behavior and the risk for CHD on type 2 DM. The study is randomized controlled one-year intervention study with 1 year follow-up. Study subjects are adult obese (BMI\>35) subjects with comorbid depression. Number of randomized study subjects will be 80, 40 in intervention group, 40 in control group. Intervention group will proceed through a 52-week CBT-based weight loss group intervention. The aim of the intervention is to modify eating behavior and lifestyle factors affecting weight and weight maintenance. There will be 22 group counselling of 90 minutes divided in five modules and also three individual person-centered counselling visit, during which participants had an opportunity to discuss their personal concerns about diet and weight loss plan. Control group will receive the usual care of obesity in Kuopio University hospital. (4-8 individual 45-minute visit conducted by dieticians) Study visits are at baseline and one and 2 years after baseline. For example eating behavior, health behavior, motivation and depression are studied with questionnaires. Weight, waist circumference, height and blood pressure are measured. Laboratory tests (lipid, glucose etc) are taken.

Interventions

BEHAVIORALCBT-based weight loss model

Methods of cognitive behavioral psychotherapy

BEHAVIORALControl

Treatment as usual

Sponsors

University of Oulu
CollaboratorOTHER
Jyväskylä Central Hospital
CollaboratorOTHER
Oulu University Hospital
CollaboratorOTHER
University of Eastern Finland
CollaboratorOTHER
Kuopio University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Randomized intervention study

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Age 18-65 years * Diagnosed depression ( F32.0, F32.1, F32.2, F33.0, F33.1, F33.2) * BMI \> 35

Exclusion criteria

* Psychotic disorder, schizoaffective disorder, psychotic depression or bipolar disorder * Severe current substance abuse * Serious psychiatric condition (i.e self-destructive or impulsive behavior) * Clinically significant illness contraindicating weight loss (i.e cancer or severe heart disease) * Simultaneous participation in another weight loss program * Severe vision, hearing, motoric deficiency

Design outcomes

Primary

MeasureTime frameDescription
Change in Weightbaseline and change from baseline to 1 year and 2 yearsMeasured by scale on baseline, 1 year and 2 years
Change in Lipidsbaseline and change from baseline to 1 year and 2 yearsMeasured by laboratory analyses (total cholesterol,High-density lipoprotein, Low-density lipoprotein, Triglyserides
Change in Blood glucosebaseline and change from baseline to 1 year and 2 yearsMeasured by laboratory analyses
Change in c-reactive protein levelbaseline and change from baseline to 1 year and 2 yearsMeasured by laboratory analyses
Change in Glycated hemoglobin (HbA1c)baseline and change from baseline to 1 year and 2 yearsMeasured by laboratory analyses
Change in Waist circumferencebaseline and change from baseline to 1 year and 2 yearsMeasured by tape measure on baseline, 1 year and 2 years

Secondary

MeasureTime frameDescription
Previous weight lossbaselineassessed by questioinnaire
Change in Moodbaseline and change from baseline to 1 year and 2 yearsassessed by BDI (Beck Depression Inventory) questionnaire
Change in Anxietybaseline and change from baseline to 1 year and 2 yearsassessed by BAI (Beck Anxiety Inventory) questionnaire
Change in Eating behavior assessed by TFEQ-18 questionnairebaseline and change from baseline to 1 year and 2 yearsThree Factor Eating questionnaire-18 measures three eating behavior traits: emotional eating, cognitive restraint and uncontrolled eating.
Change in Self-efficacy: questionnairebaseline and change from baseline to 1 year and 2 yearsassessed by WEL questionnaire
Change in Sense of coherencebaseline and change from baseline to 1 year and 2 yearsassesed by SOC13 (Sense of Coherence) questionnaire
Change in Quality of lifebaseline and change from baseline to 1 year and 2 yearsAssesed by 15D questionnaire
Change in Eating behavior assessed by BES-questionnairebaseline and change from baseline to 1 year and 2 yearsBES -questionnaire assess binge eating symptoms.
Change in Intuitive Eating behaviorbaseline and change from baseline to 1 year and 2 yearsassessed by IES2 (Intuitive Eating Scale) questionnaire,
Change in Physical acitivitybaseline and change from baseline to 1 year and 2 yearsassessed by questionnaire assessing physical activity
Change in Sleepbaseline and change from baseline to 1 year and 2 yearsassessed by questionnaire
Change in Use of alcohol and tobaccobaseline and change from baseline to 1 year and 2 yearsassessed by questionnaire

Countries

Finland

Contacts

Primary ContactAnna-Maria Teeriniemi, PhD
anna-maria.teeriniemi@kuh.fi+358447113148
Backup ContactSanna Rajapolvi, MSc
sanna.rajapolvi@kuh.fi+358447176209

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026